New Market Study, "Gamma Therapeutics, Inc. - Product Pipeline Analysis, 2013 Update", Has Been Published
Gamma Therapeutics, Inc. (Gamma Therapeutics) is a biotechnology company. The company develops biopharmaceutical and diagnostic solutions for cardiovascular disease risk assessment, surgical therapy and combat casualty care. Its products include GammaCoeur, GammaSeal and Gammarin. The company's GammaCoeur is a cardiovascular disease diagnostic assay for prognosis and preventative care. Gamma Therapeutics GammaSeal is a natural surgical sealant for large artery vascular surgery and Gammarin, a non-immunogenic anti-coagulant blood thinner for post-surgical venous thromboembolism control which is currently under development. Its products...
View full press release